Requirement of a carbon spacer in benzyl isothiocyanate-mediated cytotoxicity and MAPK activation in head and neck squamous cell carcinoma

被引:42
作者
Lui, VWY
Wentzel, AL
Xiao, D
Lew, KL
Singh, SV
Grandis, JR [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA
关键词
D O I
10.1093/carcin/bgg127
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cruciferous vegetable-derived isothiocyanates (ITCs; chemical structure: R-N=C=S) are highly effective in affording protection against chemically induced cancers in animal models. Here, we studied the antitumor effects of benzyl isothiocyanate (BITC; Ph-CH2-N=C=S), the predominant ITC compound in broccoli, on head and neck squamous cell carcinoma (HNSCC) cell lines. Proliferation, apoptosis and immunoblotting assays were used to determine the effects and mechanism of several ITCs on HNSCC cells. The IC50 for BITC (24 h treatment) in two of the HNSCC cell lines was similar to22 and 17 muM, respectively. Interestingly, phenyl isothiocyanate (PITC; Ph-N=C=S), which is a close structural analog of BITC but lacks a -CH2- spacer that links the aromatic ring to N=C=S moiety, did not result in significant killing of the HNSCC cells in this dose range. BITC (but not PITC) caused activation of caspase 3 and PARP cleavage. Within 20 min of treatment, BITC (but not PITC) induced a rapid activation of p38 MAPK. In addition, BITC (but not PITC) treatment resulted in the activation of p44/42 MAPK. Co-treatment with a specific p38 MAPK inhibitor, SB203580, or an inhibitor of the MEK/MAPK pathway, U0126, partially rescued cells from BITC-induced killing. Our results show that minor structural differences in ITCs can be crucial for the antiproliferative activity of ITCs and that BITC may be a promising chemopreventive as well as therapeutic agent in HNSCC.
引用
收藏
页码:1705 / 1712
页数:8
相关论文
共 40 条
[1]   Inhibition of human leukaemia 60 cell growth by mercapturic acid metabolites of phenylethyl isothiocyanate [J].
Adesida, A ;
Edwards, LG ;
Thornalley, PJ .
FOOD AND CHEMICAL TOXICOLOGY, 1996, 34 (04) :385-+
[2]  
Bonnesen C, 2001, CANCER RES, V61, P6120
[3]   Molecular mechanisms of c-Jun N-terminal kinase-mediated apoptosis induced by anticarcinogenic isothiocyanates [J].
Chen, YR ;
Wang, WF ;
Kong, ANT ;
Tan, TH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (03) :1769-1775
[4]  
Crowe DL, 2002, HISTOL HISTOPATHOL, V17, P909, DOI 10.14670/HH-17.909
[5]  
Dunnick J K, 1982, Fundam Appl Toxicol, V2, P114, DOI 10.1016/S0272-0590(82)80091-2
[6]   The chemical diversity and distribution of glucosinolates and isothiocyanates among plants [J].
Fahey, JW ;
Zalcmann, AT ;
Talalay, P .
PHYTOCHEMISTRY, 2001, 56 (01) :5-51
[7]   EFFECTS OF PHENETHYL ISOTHIOCYANATE, A CARCINOGENESIS INHIBITOR, ON XENOBIOTIC-METABOLIZING ENZYMES AND NITROSAMINE METABOLISM IN RATS [J].
GUO, ZY ;
SMITH, TJ ;
WANG, E ;
SADRIEH, N ;
MA, Q ;
THOMAS, PE ;
YANG, CS .
CARCINOGENESIS, 1992, 13 (12) :2205-2210
[8]   EFFECTS OF ISOTHIOCYANATE ALKYL CHAIN-LENGTH ON HAMSTER LIVER CYTOCHROME-P-450 ACTIVITY [J].
HAMILTON, SM ;
ZHANG, Z ;
TEEL, RW .
CANCER LETTERS, 1994, 82 (02) :217-224
[9]  
HEO DS, 1989, CANCER RES, V49, P5167
[10]  
Huang CS, 1998, CANCER RES, V58, P4102